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SUMMARY
 Dissemination of  Acinetobacter baumannii strains in  different units of a hospital in Sorocaba, São Paulo, Brazil was evaluated
over a period of two years. By using biotyping, serotyping and ribotyping, 27 distinct clones were differentiated among 76 strains
isolated between 1993-94, from clinical specimens of hospitalized patients. Two clones, 2:O4:A (biotype:serotype:ribotype) and
2:O29:A accounted for the majority  of strains widely disseminated in the units during 1993. The introduction in the hospital setting,
of a new clone, 6:O13:B, at the end of 1993 and its  predominance  through 1994 is discussed. Among 15 strains isolated from
neonates, 6 (40%) belonged to the same clone, 2:O4:A. Interestingly, this clone was almost all recovered  in  neonatal intensive care
unit, nursery and in pediatric unit. All strains were susceptible to imipenem and polymyxcin B.  Multiresistant  strains (up to 12
antimicrobial agents) accounted for 66.7% and 84.8%  of the strains isolated in 1993 and in 1994, respectively.
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INTRODUCTION
Among 21 genomic species recognized within the genus
Acinetobacter5,7,12,27, Acinetobacter baumannii has been found  most
frequently associated with outbreaks of  nosocomial infections2,4,6,24
although other species like Acinetobacter genomic species 3 and 13 have
also been implicated5,6. A number of factors as immunosuppresion, age,
surgery, underlying diseases, use of invasive devices and antimicrobial
agents etc, have been reported as increasing the risk of infection or
colonization by these opportunistic pathogens3,16,26.
The emergence and increase of antibiotic multiply-resistant strains
of A. baumannii2,13,23,31 and the remarkable capacity of long-term survival
in hospital environment which favors their spreading, represent a serious
challenge in infection control.
The natural habitat of A. baumannii remains still unknown25.
Although this microorganism is the most frequently implicated genomic
species in hospital infections, it is rarely found in human skin in contrast
to other Acinetobacter species which can  form part of  the normal
bacterial flora of skin1,25.
Persistence of epidemic strains of Acinetobacter on equipment or
other materials of hospital units, even after the discharge of colonized
patients, probably  is responsible for long-term outbreaks and for the
occurrence of endemic nosocomial infections in patients of many units.
The purpose of this study was to characterize phenotypically and
genotypically  A. baumannii strains isolated from patients hospitalized
in different medical care units between 1993-94 and to evaluate the
dissemination of particular clones through the hospital units.
MATERIAL AND METHODS
Bacterial strains. A total of 76 strains of A. baumannii isolated
between 1993-94 were studied. These strains were isolated from patients
hospitalized in different units of a general hospital in Sorocaba, São
Paulo State, Brazil. Forty four strains were from secretions (respiratory
tract, wounds, surgical wounds), 14 from catheter tip, 6 from effluent
filter, 6 from blood, 4 from urine, and 2 from pleural fluid. All strains
were identified as A. baumannii according to BOUVET & GRIMONT5
in the Regional Laboratory of Sorocaba and sent to the Central Laboratory
for further characterization.
Biotyping and serotyping. All strains were biotyped following the
method described by BOUVET & GRIMONT6 using levulinate,
citraconate, L-phenylalanine, phenylacetate, 4-hydroxybenzoate and L-
tartarate in carbon source utilization test. Serotypes were determined
using 34 O-antisera prepared with reference strains of A. baumannii.
Tube agglutination test was done according to TRAUB28 with minor
modifications19,29.
Antimicrobial susceptibility test. Antimicrobial resistance patterns
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were determined by using agar diffusion method according to the National
Committee for Clinical Laboratory Standards17 for susceptibility to
cefotaxime (30 g), ceftazidime (30 g), imipenem (15 g), ampicillin
(33 g), ticarcillin/clavulanic acid (75/10 g), gentamicin (10 g),
tetracycline (80 g), sulfamethoxazole/trimethoprim (25 g), amikacin
(30 g), ciprofloxacin (5 g), tobramycin (10 g), netilmicin (30 g),
polymyxin B (300 IU), streptomycin (10 g), kanamycin (30 g). All
antimicrobial drugs were from Cecon - Centro de Controle e Produtos
para Diagnóstico Ltda, São Paulo, Brazil. Pseudomonas aeruginosa
ATCC 27853, Escherichia coli ATCC 25922, Staphylococcus aureus
ATCC 25923, and E. faecalis ATCC 29212 were used as control strains.
Ribotyping. All strains were ribotyped. Bacterial DNA was extracted
as described elsewhere9. Five g of DNA samples were digested with
EcoRI following the instructions of the manufacturer (Pharmacia-LKB).
After agarose gel electrophoresis, the fragments were transferred to nylon
membranes using a vacuum blotter (Vacugen, Pharmacia-LKB) with
20xSSC as the transfer solution. Membranes were hybridized with a
digoxigenin-11-dUTP-labelled cDNA probe derived from E. coli 16+23S
rRNA prepared by random priming using reverse transcriptase.
Hybridization conditions were essentially as described by POPOVIC et
al.20. H. aegyptius 3031 EcoRI DNA digest (fragments of 1.5 to 17.6
kb) was used as molecular marker. Fragment sizes were estimated using
a computer program (DNASTAR Computer System for Molecular
Biology and Genetics, London, UK) and capital letters were used to
identify the ribotypes. In order to confirm the distinct ribotypes obtained
after digestion with EcoRI, DNA samples of representative strains of
each ribotype were clived with a second enzyme HindIII.
RESULTS
Biotyping and serotyping. Overall two biotypes, biotype 2 and
biotype 6, accounted for 85.5% of strains. Biotype 2 (63.8%)
predominated among strains isolated in 1993, whereas biotype 6 (62.5%)
strains were the most frequent in 1994 followed by biotype 2 strains
(37.5%). Serotyping was more discriminatory than biotyping. Among
76 strains, 63 (82.9%) were typable and 12 serotypes were encountered.
Four serotypes, O29 (26.3%), O13 (21.0%), O4 (10.5%) and O11 (7.9%),
predominated in our sample (Table 1).
Antimicrobial susceptibility test. Of 30 strains isolated in 1993,
6.7% were susceptible to all tested drugs while 66.7% were multiple-
resistant to more than 4 and up to 12 antimicrobial drugs. Of the 46
strains recovered in 1994, 4.3% were susceptible to all antimicrobials
and 84.8% were multiple resistant up to 12 tested drugs. In Table 3 are
listed all the antimicrobial resistance patterns seen in the four predominant
clones (2:O29:A, 2:O4:A, 2:O11:A, and 6:O13:B) isolated during 1993-
94.
Ribotyping. Thirteen distinct ribotypes arbitrarily named A to M
were obtained after DNA digestion with EcoRI. Two ribotypes, A (52.6%)
and B (27.6%) predominated among 76 strains. The banding patterns in
the blot of representative ribotypes are shown in Fig. 1. Fig. 1a shows
12 of 13 banding patterns found among our strains when digested with
EcoRI. Ribotype G is not shown because of its incomplete digestion in
this blot. EcoRI was more discriminatory than HindIII as we can see in
Fig.1b, where ribotypes D and E displayed the same banding pattern
after digestion with HindIII.
Table 1
Annual distribution of  A. baumannii clones characterized by the association
of  biotype, serotype and ribotype
Clones  1993 1994 Total of strains
(Biotype/Serotype/Ribotype)
2/O4/A 6 2 8
2/O11/A - 5 5
2/O13/C 1 - 1
2/O15/D - 1 1
2/O28/A - 1 1
2/O29/A 14 4 18
2/O32/A - 1 1
2/ONT/A 2 1 3
5/O1/L - 1 1
6/O1/B - 1 1
6/O13/B 1 13 14
6/O13/M 1 - 1
6/O15/D - 1 1
6/O19/E - 1 1
6/O32/B - 3 3
6/ONT/B - 3 3
6/ONT/D - 2 2
6/O29/A - 1 1
8/O7,14/J 1 - 1
8/O11/I 1 - 1
8/ONT/A 1 - 1
9/O30/A 1 1 2
9/”R”/G 1 - 1
9/ONT/A 1 - 1
9/ONT/H - 1 1
11/ONT/F - 1 1
Nd/O29/K 1 1
Total 32 44 76
“R”, rough strain; ONT, non-typable with 34 O-antisera; Nd/O29/K, biotype
not determined.
Combination of typing results. By combining the results obtained
with biotyping, serotyping and ribotyping, 27 clones were distinguished
among 76 strains. Four clones, 2:O4:A, 2:O11:A, 2:O29:A, and 6:O13:B,
were the most frequently recovered ones in different hospital units. The
majority of strains of biotype 2, irrespective of the serotype were
associated with ribotype A. On the other hand, 77% of strains belonging
to biotype 6 were related to ribotype B. The distribution of all clones
according to the care units is shown in Table 2. Clones characterized as
2:O4:A and 2:O29:A predominated among strains isolated in 1993,
whereas strains belonging to clone 6:O13:B were the most frequent in
1994. All strains belonging to biotype 2 and to serotype O29 were
ribotype A. On the other hand all strains of biotype 6 and serotype O13
were ribotype B. No specific antimicrobial resistance patterns were
associated with distinct clones. Distinct antimicrobial resistance patterns
associated with the main clones are shown in Table 3.
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Table 2
Distribution according to the hospital units of A. baumannii clones characterized by the association of biotype:serotype:ribotype isolated between 1993-94
A. baumannii clones
Units 2:O4:A 2:O11:A 2:O29:A 2:Od:Rd 5:O1:R 6:O13:B 6:Od:Rd 8:Od:Rd 9:Od:Rd 11:ONT:H Nd:O29:K
 NICU  3 1 1  1  1  1
AICU 1 4 2 1 1
BN 3 1
PED 1 2 1 1
GM 1 1 1
NPH 1 1 1 3 4 1
PN 1 1
CV 1 1 1 1
END 1
GS 4 1 2
ONC 1
THOR 1 1 1
URO 1
ORT 1 1 1
NEU 1 1
UNK 2 3 3 3 1
Total 8 5 18 7 1 14 13 3 5 1 1
2:Od:Rd = biotype 2: different serotypes (O13;O15;O28;O32; ONT): different ribotypes (A;C;D);  6:Od:Rd = biotype 6: different serotypes
(O1;O13;O15;O19;O29;O32; ONT): different ribotypes (A;B;D;E;M); 8:Od:Rd = biotype 8: different serotypes (O7,14;O11;ONT): different ribotypes (A;J;I);
9:Od:Rd = biotype 9: different serotypes (O30;ONT): different ribotypes (A;G;H) Nd:O29:K (biotype not determined/serotype O29/ribotype K); Units - NICU
(neonatal intensive care unit); AICU (adult intensive care unit); BN (nursery); PED (pediatric); GM (general medicine); NPH (nephrology); PN (pulmonary); CV
(cardiovascular); END (endocrinology); GS (general surgery); ONC (oncology); THOR (thoracic); URO (urology); ORT (orthopedic); NEU (neurology); UNK
(unknown).
Fig. 1 - Banding patterns of A. baumannii generated by EcoRI (1a) and by HindIII (1b). Size marker (H. aegyptius 3031 EcoRI DNA digest, fragment sizes in kilobases) in lanes 1 and 8 (Fig.
1a) and 1 and 9 (Fig. 1b). In Fig. 1a , ribotypes A, B, C, D, E, F, H, I, J, K, L and M are in lanes, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13 and 14, respectively. Ribotype G obtained after digestion with
EcoRI is not shown in this blot. In Fig. 1b, ribotypes A, B, C, D, F, G, H, I, J, K, L, and M are shown in lanes 2, 3, 4, 5 and 6, 7, 8, 10, 11, 12, 13, 14, and 15, respectively. Ribotypes D and E
obtained after digestion with EcoRI displayed the same profile when clived with HindIII (lanes 5 and 6 of Fig.1b).
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Table 3
Antimicrobial resistance patterns of four main clones of Acinetobacter baumannii isolated during the period 1993-94
Clone Total of Strains Unit Year of  Isolation Antimicrobial  Resistance Patterns
2:O4:A 1 NICU 1993 ET
1 PED 1993 AM AP CIP CTX ET GN KN SFT TB TT
1 NICU 1993 AM AP CAZ CIP CTX GN ET KN SFT TB TIC TT
2 NICU/BN 1993 AM AP CAZ CTX ET GN KN SFT TB
1 CV 1994 AM AP CAZ CIP CTX ET KN SFT TIC
1 BN 1993 AM AP CAZ CTX ET GN KN SFT TB TIC
1 BN 1993 AM AP CAZ CIP CTX ET GN KN SFT TB TIC TT
2:O11:A 1 GM  1994 AM AP CAZ CTX ET KN SFT
2 NPH/UNK 1994 AM AP CAZ CIP CTX ET KN SFT TT
1 AICU 1994 AM AP CAZ CIP CTX ET GN KN SFT TIC TT
1 UKN 1994 AM AP CAZ CIP CTX ET GN KN SFT TB TT
2:O29:A 1 UNK 1993 AP TT
1 UNK 1994 AM AP ET KN SFT
2 NPH/AICU 1993 AM AP CTX ET KN SFT
2 AICU/CV 1993 AM AP CAZ CTX ET KN SFT
1 THOR 1993 AM AP CTX ET KN SFT TT
2 GS/AICU 1993 AM AP CAZ CTX ET KN SFT TIC
1 ONC 1993 AM AP CTX  ET GN KN SFT TB
2 GS/END 1993 AM AP CAZ CTX ET KN SFT TT
2 GS/ORT 1993-94 AM AP CAZ CTX ET GN KN SFT TB
1 UNK 1993 AM AP CAZ CTX ET GN KN SFT TIC TT
1 AICU 1994 AM AP CAZ CTX ET GN KN SFT TB TIC
1 GM 1994 AM AP CAZ CTX ET GN KN SFT TB TT
1 GS 1994 AM AP CAZ CTX ET GN KN SFT TIC TB TT
6:O13:B 1 PED 1994 AP
1 NPH 1994 AM GN NET TB
1 UNK 1994 AP CAZ CTX KN NET
1 NPH 1994 CAZ CTX KN NET TB
1 NPH 1994 AP CAZ CTX KN NET TB
1 AICU 1994 AM AP CIP CTX KN NET TB
1 NEU 1994 AM AP CTX ET KN NET TB
1 UNK 1994 AM AP CAZ CTX ET GN KN NET TB
1 GS 1994 AM AP ET GN KN NET SFT TB TT
1 PN 1994 AP CTX GN ET KN NET SFT TB TIC TT
1 GS 1994 AM AP CAZ CTX ET GN KN NET TB TT
1 ORT 1994 AM AP CTX ET KN NET SFT TB TIC TT
1 PED 1993 AM AP CAZ CTX GN KN NET SFT TB TIC TT
1 UNK 1994 AM AP CAZ CTX  ET GN KN NET SFT TB TIC TT
Amikacin (AM); Ampicillin (AP); Ceftazidime (CAZ); Cefotaxime (CTX); Ciprofloxacin (CIP); Streptomycin (ET); Gentamicin (GN); Kanamycin (KN);
Netilmycin (NET); Sulfamethoxazole/Trimethoprim (SFT); Tobramycin (TB); Ticarcillin/Clavulanic acid (TIC); Tetracycline (TT) Units - NICU* (neonatal
intensive care unit); AICU (adult intensive care unit); BN (nursery); PED (pediatric); GM (general medicine); NPH (nephrology); PN (pulmonary); CV
(cardiovascular); END (endocrinology); GS (general surgery); ONC (oncology); THOR (thoracic);  ORT (orthopedic); NEU (neurology);  UNK (unknown).
DISCUSSION
Many reports have documented the ubiquitous nature of
Acinetobacter spp, opportunistic pathogens frequently implicated in
epidemics of hospital infections1,4,14. Differentiate epidemic strains from
numerous incidental strains found in hospital environment require a
precise discrimination among strains within the species.
Among a variety of methods proposed for strain typing, we used
biotyping, serotyping and ribotyping to evaluate the spreading of A.
baumannii in medical care units. As previously reported8, biotyping
proved to be an easy and appropriated method for screening strains.
This method differentiated our 76 strains into six categories with
predominance of biotypes 2, 6 and 9 which were already reported as
frequently recovered from clinical specimens6,8,19,29 . Heterogeneity of
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strains of same biotype was further identified with serotyping. Although
the great majority of biotype 2 strains were associated with serotypes
O29 and O4, other three more serotypes were also identified. The same
observation was made on the biotype 6 strains which were associated
with six different serotypes with the predominance of the biotype 6/
serotype O13 association. OLIVEIRA et al.19, showed that strains of A.
baumannii belonging to biotype 2/serotype O29 as well as strains of
biotype 6/serotype O13 were predominant among strains isolated both
from inpatients and outpatients of two hospitals in São Paulo, Brazil. It
is worth noting that serotype O29 was recently identified among Brazilian
strains as one of the prevalent serotypes19,29. Although rarely applied19,28,29
serotyping in combination with other methods can be useful for
epidemiological studies.
Ribotyping has been used as a taxonomic tool particularly to
differentiate strains of  Acinetobacter calcoaceticus-Acinetobacter
baumannii complex  as well as in the differentiation of strains implicated
in outbreaks10,11,21. In this study ribotyping was used as an additional
method to allocate phenotypically defined strains to a given clone. Clone
2:O29:A strains were isolated in 10 of 15 studied units and were mainly
from adults. Another widely disseminated clone was 6:O13:B (in 9 of
15 evaluated units), and such strains were also from adults. On the other
hand, strains belonging to the clone 2:O4:A were closely related to
infants. Among 8 strains of this clone, 6 were from neonates and one
from a one-year-old aged infant. As previously reported neonates
represent an important group of patients susceptible to the acquisition
of  bacteremia by Acinetobacter18,22. Among 76 studied strains, 15 were
from neonates, four of them with bacteremia. Interestingly, whereas all
strains recovered during 1993 in neonatal intensive care unit, nursery
and pediatric unit, belonged to the same clone 2:O4:A, in 1994, distinct
clones (2:NT:A; 6:O19:E and 9:Od:Rd) were detected in these units,
probably due to the introduction of new strains from the community by
the newly admitted patients.
The wide distribution of some clones in several wards suggests that
limited outbreaks coexisted during 1993 and 1994. The high antimicrobial
multi-resistance patterns exhibited by these strains with epidemic
potential probably contributed to their spread despite the control
measures. On the other hand many other clones, although with limited
potential of dissemination and sporadically isolated in some wards could
represent a serious challenge to infection control because of their multi-
resistance. Which characteristics of epidemic strains are associated with
the ability to disseminate through the wards and to colonize or infect a
particular host remain to be investigated.
Hospital equipment and hands of hospital staff have been reported
as reservoirs of Acinetobacter spp, but often the true source of infection
cannot be traced, because of its ubiquitous nature. Moreover, SEIFERT
et al.25, documented that the most frequent species associated with
hospital infections are rarely recovered from human skin. BOUVET &
GRIMONT6 also reported that while patients were infected with A.
baumannii, species other than A. baumannii were recovered from hands
of nurses of the same ward. Therefore to explain the introduction of new
clones such as 6:O13:B, at the end of 1993 in the hospital, we may
postulate the possibility that these strains circulate in the community
and once introduced into the hospital setting with the admission of a
patient they are selected in hospital environment probably through
selective antibiotic pressure or other still unknown epidemiological
factors. The widespread distribution of these strains in the wards is
probably associated with their ability to survive for long periods of time
on dry surfaces which favors transmission between patients via inanimate
hospital materials15,30. Continuous hospital epidemiological investigations
including a complete characterization of nosocomial strains are essential
to implement control measures of hospital infections.
RESUMO
Biotipagem, sorotipagem e ribotipagem na avaliação
epidemiológica de A. baumannii em unidades hospitalares,
Sorocaba, São Paulo, Brasil
Foi avaliada a disseminação, durante um período de dois anos, de
cepas de Acinetobacter baumannii em diferentes unidades de um hospital
de Sorocaba, São Paulo.Usando as técnicas de biotipagem, sorotipagem
e ribotipagem, as 76 cepas isoladas no período 1993-94, foram
diferenciadas em 27 distintos clones. Dois clones, 2:O4:A
(biotipo:sorotipo:ribotipo) e 2:O29:A predominaram, em 1993, entre as
cepas disseminadas nas várias unidades. Observou-se no final de 1993,
a introdução de um novo clone, 6:O13:B e a sua predominância em
1994. Entre as 15 cepas isoladas de recém nascidos, 6 (40%) pertenciam
ao mesmo clone, 2:O4:A . A maioria das cepas desse clone foram isoladas
da unidade de terapia intensiva neonatal, de berçário e de unidades
pediátricas. Quanto à resistência aos agentes antimicrobianos, todas as
cepas foram sensíveis à polimixina B e ao imipenen. Em 1993, 66,7%
das cepas eram multi-resistentes (resistentes de 4 a 12 dos 15
antimicrobianos testados), enquanto que, em 1994, 84,8% das 46 cepas
isoladas foram multi-resistentes a mais de 4 e até a 12 drogas.
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